Clinical Trials in Austin

Showing 3001-3020 of 13,060 trials

Actis Total Hip System 2 Year Follow-up

NCT02783274

Two-year (2 year) information regarding the performance of the commercially available Actis™ Total Hip System in order to obtain and evaluate the clinical outcomes on a series of cementless primary total hip arthroplasty (THA) and hemi-hip arthroplasty procedures using clinical, radiographic and device and procedure related adverse event assessments.

OsteoarthritisTraumatic ArthritisRheumatoid Arthritis+6 more

DePuy Orthopaedics266 participantsStarted Jul 2016

Louisville, Kentucky, United States • Boston, Massachusetts, United States • Rochester, Minnesota, United States +6 more locations

COMPLETEDPhase 2< 1 mile

Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

NCT05383209

A prospective, randomized, double-masked study that evaluated the ocular efficacy and safety of two doses of the EYP-1901 intravitreal (IVT) insert compared to sham.

Nonproliferative Diabetic Retinopathy

EyePoint Pharmaceuticals, Inc.77 participantsStarted Sep 2022

Phoenix, Arizona, United States • Huntington Beach, California, United States • Oxnard, California, United States +33 more locations

Actis Total Hip System 2 Year Follow-up

Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

Find Trials by Condition in Austin

Topical ENS-002 for Atopic Dermatitis in Adults

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus

Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis

Efficacy and Safety of Pembrolizumab (MK-3475) With Lenvatinib (E7080/MK-7902) vs. Docetaxel in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease (PD) After Platinum Doublet Chemotherapy and Immunotherapy (MK-7902-008/E7080-G000-316/LEAP-008)

Observational Evaluation of Atopic Dermatitis in Pediatric Patients

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Lupus Landmark Study: A Prospective Registry and Biorepository

Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)

Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)

Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma